These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25311380)

  • 1. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
    Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
    Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
    Zhou X; Chen C; Yin D; Zhao F; Bao Z; Zhao Y; Wang X; Li W; Wang T; Jin Y; Lv D; Lu Q; Yin X
    Intern Med; 2019 Aug; 58(16):2341-2347. PubMed ID: 31118371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
    Shang Z; Han F; Zhou X; Bao Z; Zhu J; Wang T; Lu Q; Du L; Li W; Lv D; Yin X
    Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
    Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX
    Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
    Wang T; Song JF; Zhou XY; Li CL; Yin XX; Lu Q
    BMC Med Genomics; 2021 Nov; 14(1):267. PubMed ID: 34772419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
    Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
    Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ
    Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
    Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
    Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ
    Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of
    Song J; Li N; Hu R; Yu Y; Xu K; Ling H; Lu Q; Yang T; Wang T; Yin X
    Front Endocrinol (Lausanne); 2022; 13():949990. PubMed ID: 36051387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
    Dai XP; Huang Q; Yin JY; Guo Y; Gong ZC; Lei MX; Jiang TJ; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):462-8. PubMed ID: 22414228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
    Wang S; Se YM; Liu ZQ; Lei MX; Hao-BoYang ; Sun ZX; Nie SD; Zeng XM; Wu J
    Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
    Zhou X; Zhu J; Bao Z; Shang Z; Wang T; Song J; Sun J; Li W; Adelusi TI; Wang Y; Lv D; Lu Q; Yin X
    Sci Rep; 2016 Nov; 6():37293. PubMed ID: 27857189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
    Ye HD; Li YR; Hong QX; Zhou AN; Zhao QL; Xu LM; Xu MQ; Xu XT; Tang LL; Dai DJ; Jiang DJ; Huang Y; Wang DW; Duan SW
    Genet Mol Res; 2015 Jun; 14(2):6350-9. PubMed ID: 26125839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
    Yu M; Xu XJ; Yin JY; Wu J; Chen X; Gong ZC; Ren HY; Huang Q; Sheng FF; Zhou HH; Liu ZQ
    Clin Pharmacol Ther; 2010 Mar; 87(3):330-5. PubMed ID: 20054294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
    Tang L; Lü Q; Cao H; Yang Q; Tong N
    Gene; 2016 Jul; 585(2):191-5. PubMed ID: 26915488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.
    Huang Y; Nie S; Zhou S; Li K; Sun J; Zhao J; Fei B; Wang Z; Ye H; Hong Q; Gao X; Duan S
    Biomed Pharmacother; 2015 Mar; 70():7-11. PubMed ID: 25776471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
    He YY; Zhang R; Shao XY; Hu C; Wang CR; Lu JX; Bao YQ; Jia WP; Xiang KS
    Acta Pharmacol Sin; 2008 Aug; 29(8):983-9. PubMed ID: 18664331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
    Qin W; Zhang R; Hu C; Wang CR; Lu JY; Yu WH; Bao YQ; Xiang KS; ; Jia WP
    Acta Pharmacol Sin; 2010 Apr; 31(4):450-4. PubMed ID: 20305679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.